BBCVirtus LifeSci Biotech Clinical Trials ETF
Grow my money#1537 of 2944 for Grow my money
Seeks investment results that correspond to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index.
Virtus · Since 2014 (11 years)
Annual Cost
0.65%
#3117 out of 5,332 ETFs
Fund Size
$35M
#3645 out of 5,332 ETFs
Dividend Yield
1.57%
Track Record
11 years
#1266 out of 5,332 ETFs
Performance
1 Year
+133.4%
3 Years
+25.5%
5 Years
-2.7%
What's inside
Asset class
Region
Strategy
index tracking
Cap
multi cap
Focus
Biotech & Genomics
Asset allocation
Stocks
99.8%
Cash
0.2%
Sector breakdown
Healthcare
100.0%
Top holdings
Erasca IncERAS3.5%
Enliven Therapeutics IncELVN1.8%
Tango Therapeutics IncTNGX1.7%
Dianthus Therapeutics IncDNTH1.5%
Alumis IncALMS1.5%
Corvus Pharmaceuticals IncCRVS1.3%
Rezolute IncRZLT1.3%
Tyra Biosciences IncTYRA1.3%
CG Oncology IncCGON1.3%
Oruka Therapeutics IncORKA1.2%
Risk profile
Volatility (1Y)
36.9%
High
Max drawdown
-76.9%
Worst peak-to-trough loss
Sharpe (3Y)
0.71
Decent risk-adjusted returns
Sortino (3Y)
1.04
Good downside protection
Similar ETFs
Data updated on 2026-05-05